Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health


Personal tools

You are here: Home / Sites / Vanderbilt -Ingram Cancer Center / Muterspaugh, Anel W

Muterspaugh, Anel W (M.P.H.)

Staff, Vanderbilt -Ingram Cancer Center, 615-936-4244

Contact Information


To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

Protocol Name Biomarkers Datasets
Lung Reference Set A Application: Pierre Massion-Vanderbilt (2017) 0 0
Nashville Early Diagnosis Lung Cancer Project 0 0
Validation of Molecular Biomarkers for the Early Detection of Lung Cancer in the setting of Indeterminate Pulmonary Nodules (Lung Team Project #2) 0 0

Closed Protocols

Protocol Name Biomarkers Datasets
Standard Specimen Reference Set: Lung 0 0


Publication Name PubMed ID Journal
Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer. 23940286 J. Natl. Cancer Inst.
Toward rapid, high-sensitivity, volume-constrained biomarker quantification and validation using backscattering interferometry. 24954171 Anal. Chem.
Biomarkers to the rescue in a lung nodule epidemic. 24516023 J. Clin. Oncol.
A 3q gene signature associated with triple negative breast cancer organ specific metastasis and response to neoadjuvant chemotherapy. 28387221 Sci Rep
The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancer. 27882349 JCI Insight
Lung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repository. 26801409 BMC Pulm Med
Identification of Proteomic Features To Distinguish Benign Pulmonary Nodules from Lung Adenocarcinoma. 28731711 J. Proteome Res.
Integrated digital error suppression for improved detection of circulating tumor DNA. 27018799 Nat. Biotechnol.
The Pursuit of Noninvasive Diagnosis of Lung Cancer. 27732989 Semin Respir Crit Care Med
Validation of a multiprotein plasma classifier to identify benign lung nodules. 25590604 J Thorac Oncol
Indeterminate pulmonary nodules: risk for having or for developing lung cancer? 25348855 Cancer Prev Res (Phila)
Reproducibility of Volumetric Computed Tomography of Stable Small Pulmonary Nodules with Implications on Estimated Growth Rate and Optimal Scan Interval. 26379272 PLoS ONE
Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis. 25247519 JAMA
Radiological Image Traits Predictive of Cancer Status in Pulmonary Nodules. 27663588 Clin. Cancer Res.
Early detection of NSCLC with scFv selected against IgM autoantibody. 23585862 PLoS ONE
Predicting lung cancer prior to surgical resection in patients with lung nodules. 25170644 J Thorac Oncol
Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity. 25073001 Am. J. Respir. Crit. Care Med.
A blood-based proteomic classifier for the molecular characterization of pulmonary nodules. 24132637 Sci Transl Med
Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma Metastasis. 27554763 Cancer Prev Res (Phila)
Advanced imaging (positron emission tomography and magnetic resonance imaging) and image-guided biopsy in initial staging and monitoring of therapy of lung cancer. 23708067 Cancer J
Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer. 27615397 J Thorac Oncol
Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial. 27509046 PLoS ONE
Targeting nucleophosmin 1 represents a rational strategy for radiation sensitization. 25035215 Int. J. Radiat. Oncol. Biol. Phys.
Biomarkers of risk to develop lung cancer in the new screening era. 27195276 Ann Transl Med
Secretory IgA from submucosal glands does not compensate for its airway surface deficiency in chronic obstructive pulmonary disease. 26432569 Virchows Arch.
Lung cancer screening and smoking cessation: a teachable moment? 24872542 J. Natl. Cancer Inst.

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.


2141 Blakemore Avenue
Vanderbilt -Ingram Cancer Center

To update addresses, please visit the Data Management and Coordinating Center.

Announcement 03/14/2018
Thank you to everyone to made the 10th EDRN Scientific Workshop a success. The next event is the 33rd EDRN Steering Committee Meeting from September 5-6, 2018 in Boston, MA. Details will be available soon.

Three new FOAs on the Human Tumor Atlas and associated with the Cancer Moonshot Initiative have been released. Please click here for more information.

Announcement 10/23/2017

Three new FOAs on the Human Tumor Atlas and associated with the Cancer Moonshot Initiative have been released. Please click here for more information.

EDRN Founder Honored

Dr. Sudhir Srivastava was honored with the Distinguished Service Award from the American Pancreatic Association at the group's annual meeting this year, for his outstanding commitment to pancreatology.